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Abstract
Summary Diabetic obesity is associated with increased
fracture risk in adults and adolescents. We find in both
adolescent and adult mice dramatically inferior mechanical
properties and structural quality of cortical bone, in
agreement with the human fracture data, although some
aspects of the response to obesity appear to differ by age.
Introduction The association of obesity with bone is
complex and varies with age. Diabetic obese adolescents
and adult humans have increased fracture risk. Prior studies
have shown reduced mechanical properties as a result of
high-fatdiet(HFD) butdonotfullyaddresssize-independent
mechanical properties or structural quality, which are
important to understand material behavior.
Methods Cortical bone from femurs and tibiae from two
age groups of C57BL/6 mice fed either HFD or low-fat diet
(LFD) were evaluated for structural and bone turnover
changes (SEM and histomorphometry) and tested for
bending strength, bending stiffness, and fracture toughness.
Leptin, IGF-I, and non-enzymatic glycation measurements
were also collected.
Results In both young and adult mice fed on HFD, femoral
strength, stiffness, and toughness are all dramatically lower
than controls. Inferior lamellar and osteocyte alignment also
point to reduced structural quality in both age groups. Bone
sizewaslargelyunaffectedbyHFD,althoughtherewasashift
from increasing bone size in obese adolescents to decreasing
in adults. IGF-I levels were lower in young obese mice only.
Conclusions While the response to obesity of murine
cortical bone mass, bone formation, and hormonal changes
appear to differ by age, the bone mechanical properties for
young and adult groups are similar. In agreement with
human fracture trends, adult mice may be similarly
susceptible to bone fracture to the young group, although
cortical bone in the two age groups responds to diabetic
obesity differently.
Keywords Cortical bone.Diabetes.Fracture risk.Fracture
toughness.Obesity
Introduction
The prevalence of obesity is increasing throughout the
world [1]. Among many effects, obesity is a risk factor for
bone fracture [2]; however, the risk of fracture is a complex
one that changes over the lifetime of the individual. Obese
children and adolescents tend to have an increased fracture
risk [3, 4]; non-diabetic obese adults, conversely, show the
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density has been associated with obesity [5–9], and this is
often cited as the primary reason for the observed reduction
in fractures. In children and adolescents, however, the
mechanistic picture is less clear as there are developmental
consequences of obesity, such as changes in muscle
development and posture control [10–12], which could
markedly affect fracture risk. Additionally, activity levels
may be a confounding issue, where adolescents are more
likely to participate in group sports which can lead to falls
and injury while adults are generally less active and may
not be exposed to similar falling risks. Obesity also
promotes diseases such as diabetes; indeed, fracture risk is
elevated in adults with type 2 diabetes [4]. Although
corresponding fracture rates for diabetic children have not
been reported, reduced bone mineral content and bone size
have been observed in type 1 diabetic adolescents, which
implies an increased fracture risk [13].
These observations suggest an age-dependent response
of bone to obesity, which are considered here by studying
two groups of wild-type mice: a young group and an adult
group. Fracture risk findings [3–9] would imply that adult
cortical bone tends to have a more favorable response to
increasing obesity than young cortical bone, although as
noted, complicating factors, e.g., diabetes, activity levels,
etc., may change the overall fracture risks reported by these
studies.
Studies into changes in bone mineral density and content
address an important aspect of bone fracture risk, but
further investigation into microstructural quality and me-
chanical behavior, in addition to quantitative measures such
as bone size and amount of mineral, may provide some
insight into the changes in fracture risk throughout a
lifetime. Prior work with animal models has been con-
ducted into the question of how mechanical properties of
bone are affected by both diabetic and non-diabetic obesity
[14–17], but this work primarily investigated size-
dependent mechanical properties (i.e., load, deflection, total
energy absorbed in bend), which do not permit mechanistic
delineation between the issues of the quantity vs. mechan-
ical quality of the bone. In general, a decrease in quality of
bone (i.e., reduced mechanical properties) and an increase
in quantity (i.e., larger bone dimensions and bone mineral
content) have been reported. To further characterize how
the mechanical integrity of the tissue changes with obesity,
size-independent measures such as strength, bending
modulus, and toughness must also be determined [18, 19].
Many physiologic systems are affected by obesity and
are important to consider in such a study. Obesity affects
leptin, insulin-like growth factor I (IGF-I), and advanced
glycation end-product (AGE) concentrations [7, 20, 21].
Leptin and IGF-I are both important to consider in obesity
studies because they affect, and are affected by, both
obesity and bone [20–22], as is non-enzymatic glycation
(NEG) which can affect fracture toughness through colla-
gen cross-linking [23–25]. Higher AGEs would also be a
logical consequence of a high-fat diet, which should
increase blood glucose levels, to subsequently increase the
rate of NEG.
Structural changes, such as larger bone size, have been
observed with obesity in both adolescents and adults [26–
30], and are an important characteristic to evaluate in
investigating the effects of obesity on bone fracture risk. To
provide further insight, macroscopic changes such as
femoral length, circumference at the midshaft, and bone
growth rates were performed in addition to qualitative
imaging, which is a valuable tool to show bone structure
changes and has been done in a prior study performed by
this group [19]. By combining mechanical testing, analysis
of biological factors, and structural evaluation, this study
was aimed at addressing how obesity affects cortical bone
at two stages in life, adolescence and adulthood, in an effort
to further understand what factors influence fracture risk
throughout life.
Methods
Animals
All protocols were approved by the UCSF Institutional
Animal Care and Use Committee and performed according
to federal guidelines for the care and use of animals in
research. Thirty 3-week-old and 28 15-week-old C57BL/6
male mice were fed a high-fat diet (Research Diets High-
Fat Diet 60 kcal% fat, 20 kcal% carbohydrate, 20 kcal%
protein) (n=15 young and n=14 adult, termed “yHFD” and
“aHFD” groups, respectively) or low-fat diet (Research
Diets Low-Fat Diet 10 kcal% fat, 70 kcal% carbohydrate,
20 kcal% protein) (n=15 young and n=14 adult, termed
“yLFD” and “aLFD” groups, respectively) for a diet
duration of 16 weeks. All mice, grouped in cages of five
animals each, were maintained under controlled tempera-
ture and photoperiod (12 h light, 12 h dark) with food and
water provided ad libitum. After sacrifice, all femora and
tibiae were isolated, wrapped in gauze soaked with Hanks’
Balanced Salt Solution (HBSS), and frozen at −20°C until
testing. Femora were used for mechanical testing: the left
tibiae were used for histomorphometry and the right tibiae
for AGE accumulation quantification.
Body composition
Body weight was measured starting on postnatal day 22 for
the young mice and postnatal day 106 for the adult mice.
All mice were weighed at 2-week intervals throughout the
2284 Osteoporos Int (2011) 22:2283–2293study and once prior to sacrifice. Fat and lean body mass
(FBM and LBM), percent fat, whole-body areal bone
mineral density (aBMD), and bone mineral content
(BMC) were determined at the completion of the study by
dual-energy X-ray absorptiometry (DXA), as instructed by
the manufacturer (Lunar PIXImus mouse densitometer).
Blood collection
At the end of week 16 of the study, mice were decapitated
within 30 s of handling. Blood was collected in tubes
containing ethylene-diaminetetraacetic acid (EDTA) and
plasma was immediately separated by centrifugation and
frozen at −80°C.
Blood glucose test
Blood glucose levels were measured from the tail vein
using an Ascensia ELITE XL blood glucose meter. The
fasting glucose measurement at age 19 and 31 weeks,
respectively, was performed after overnight fasting in the
last week of the study (week 16).
Leptin level measurement
Serum leptin levels were measured using a Crystal Chem
Inc. Mouse Leptin ELISA kit according to the manufac-
turer’s instructions as previously reported [19]. Both intra-
and inter-sample coefficients of variation for this test are
10%.
IGF-I level measurement
Serum IGF-I levels were measured using an Immunodiag-
nostic Systems Inc. Mouse/Rat IGF-I ELISA kit according
to the manufacturer’s instructions as previously reported
[19]. Both intra- and inter-sample coefficients of variation
for this test are 7–8%.
Bone histomorphometry measurements
Dynamic bone histomorphometric measures were obtained
from the tibial midshaft of each animal. Mice were injected
with 10 mg/kg calcein 1 and 6 days before sacrifice. At
termination, tibiae were removed and fixed in 10% neutral
phosphate-buffered formaldehyde for 24 h. Tibial mid-
diphyseal regions were cut out using a precision saw
(Isomet 1000; Buehler, Lake Bluff, IL, USA) and dehy-
drated in increasing concentrations of ethanol and embed-
ded undecalcified in methylmethacrylate. Transverse
sections (40 μm thick) of tibial cortex were cut at tibia–
fibula junction using a diamond wire saw (Well 3241,
Norcross, GA, USA). The sections were cover-slipped with
Eukitt (Calibrated Instruments, Hawthorne, NY, USA) and
mounted unstained for visualization under fluorescent
microscopy (Eclipse E400; Nikon, Japan) for quantitative
morphometry using image analysis software (Bioquant
Image Analysis Corporation, Nashville, TN, USA). Endo-
cortical and periosteal measurements included single- and
double-labeled perimeter and interlabel width, which were
used to calculate the mineralizing surface (MS/BS), mineral
apposition rate (MAR), and bone formation rate (BFR) at
both the endocortical and periosteal bone surfaces accord-
ing to the standard guidelines previously published for bone
histomorphometry [31]. For those samples not displaying a
double label, a minimum MAR was assigned (0.5 μm/day)
and was used to calculate BFR.
Quantification of advanced glycation end-product
accumulation
A fluorometric assay was performed in order to evaluate the
extent of AGEs in HFD and LFD bone. The tibial mid-
shafts were demineralized using EDTA and confirmed
using contact radiographs. The demineralized bone samples
were then hydrolyzed using 6 N HCl (24 h, 110°C). AGE
content was determined using fluorescence readings taken
using a microplate reader at the excitation wavelength of
370 nm and emission wavelength of 440 nm. These
readings were standardized to a quinine-sulfate standard
and then normalized to the amount of collagen present in
each bone sample. The amount of collagen for each sample
was determined based on the amount of hydroxyproline, the
latter being determined using a chloramine-T colorimetric
assay that recorded the absorbance of the digested samples
against a hydroxyproline standard at the wavelength of
585 nm [32].
Mechanical testing
Size-dependent measures such as failure load and energy
absorption do not account for changes in the bone cross-
section area, thereby confounding the effects of bone
quality and quantity. To understand the mechanical integrity
of the bone and its resistance to fracture, size-independent
mechanical properties (yield and maximum stresses, stiff-
ness, and fracture toughness
1) also need to be measured
1 Strength, defined by the yield stress at the onset of permanent
deformation or maximum strength at the peak load before fracture, is a
measure of the force/unit area that the bone can withstand. Stiffness is
related to the elastic modulus and defines the force required to
produce a corresponding elastic deformation (elastic strain). The
fracture toughness measures resistance to fracture of a material.
However, the overall bone fracture risk of an individual will be a
function of the bone quantity in addition to such measures of bone
quality.
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bone distribution and bone quantity measures. Prior to
t e s t i n g ,t h ef e m o r aw e r et h a w e di nr o o m - t e m p e r a t u r e
HBSS, and the size and geometry of all samples were
measured with calipers. The left femora were tested in
unnotched three-point bending to evaluate bending strength
and stiffness. The right femora were tested in notched three-
point bending to assess the fracture toughness. For
toughness testing, the femoral shaft was sharply notched
in the mid-diaphyseal region through the posterior wall
using the method described by Ritchie et al. [33]. Notches
were sharpened by polishing in 1-μm diamond paste with a
razor blade to a root radius of ∼5–10 μm. Notched and
unnotched femora were placed in a three-point bending rig
such that the posterior side was in tension and the anterior
was in compression. Femora were submerged in HBSS at
37°C for 1 min to acclimate, then tested in the same
environment at a displacement rate of 0.001 mm/s until
fracture (EnduraTec Elf 3200, BOSE). Broken halves were
then dehydrated and the fracture surfaces examined in an
environmental SEM (JEOL JSM-6430 ESEM, Hitachi
America). The femoral cross-sectional area and second
moment of inertia were computed from fracture surface
images. Notch half-crack angles were determined in the
SEM from the fracture surface using techniques described
in ref. [33]. Stresses and strains were computed in
accordance with the methods described by Akhter et al.
[34]. The yield strength (σy) was determined as the stress at
0.2% plastic strain, and maximum strength (σu) as the stress
at peak load (Pu). Bending stiffness (E) was calculated as
the slope of the linear region of the stress–strain curve.
Fracture toughness (Kc) values were defined at the onset of
unstable fracture, i.e., at the point of instability, using the
procedures described in ref. [33] for the toughness
evaluation of small animal bone.
Scanning electron microscopy
Scanning electron microscopy (SEM) was performed to
evaluate structural differences at the tissue level near the
fracture surface on the medial and lateral sides of the femur.
After mechanical testing, three samples each from the four
study groups were mounted in Buehler Epoxycure Resin
(Buehler) and the surface polished to 0.05 μm with a
diamond polishing suspension, coated with carbon, then
imaged in an SEM (Philips XL30 ESEM-FEG; FEI
Company) operating at 10 kV in back-scattered mode as
previously reported [19].
Statistical analysis
Measured values are presented as mean±standard devia-
tion. Two-tailed independent sample Student’s T tests were
executed (StatPlus:mac LE.2009) to determine differences
in measured variables between the LFD and HFD groups
for each age group. As the young and adult study groups
were considered to be independent from each other, we did
not test for changes among all groups, but rather investi-
gated whether obesity in a particular age group had an
effect on bone properties. Differences were considered to be
significant at p<0.05. Correlation analysis was performed
within each group (LFD and HFD) to identify trends that
might be diet-independent. To mitigate the risk of type I
errors, related measurements that were highly and positive-
ly correlated were grouped together and given a composite
score (sum of Z-scores). For those measures which did not
correlate to similar measurements (σu, Pu)o rw e r e
conceptually unique (Kc, aBMD), the Z-score for that
measurement was used in the analysis without any
modification. Correlation analysis was performed between
scores of predictive measures (mineral density, composite
bone size score, and two body composition measures) and
mechanical property outcomes (composite strength and
modulus score, fracture toughness, and load measures).
Results
Metabolic phenotype of experimental animals
Figure 1 summarizes the results of the weight and hormone
changes in this study. Both HFD groups were significantly
heavier than their LFD counterparts, with the aHFD group
being 52.7% heavier than the aLFD group and the yHFD
group being 44.2% heavier than the yLFD group (p<
0.0001 for both). Unsurprisingly, fat body mass (FBM) was
192% and 229% greater in adult and young HFD,
respectively, compared to aLFD and yLFD (p<0.0001).
Lean body mass (LBM) did change slightly (15% larger in
both yHFD and aHFD compared to their respective age
controls, p<0.0001); this change was likely a contributing
factor to the results observed.
Blood glucose tests indicated that the obese groups were
likely diabetic. Blood glucose levels in the obese groups
were double the levels in the low-fat fed groups (191.9±
41.1 mg/dl in aHFD vs. 99.4±29.8 mg/dl in aLFD, p<
0.001; 187.7±39.1 mg/dl in yHFD vs. 97.7±16.3 mg/dl in
yLFD, p<0.001). This result is also not surprising as the
C57Bl/6 mouse strain is known to be susceptible to
diabetes on high-fat diets.
There was a 16% increase in the serum leptin concen-
tration in aHFD vs. aLFD, and a 235% increase in yHFD
vs. yLFD (p>0.05). Although not significant due to large
variations, the increasing trend in serum leptin concentra-
tion is in agreement with prior studies showing that serum
levels of leptin increase with obesity.
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well as with greater bone size; therefore, serum IGF-1
levels were characterized in each experimental group. The
insulin-like growth hormone IGF-I concentration was 145%
larger in yHFD vs. yLFD (p<0.01).
Bone densitometry: bone mineral content but not density
smaller with high-fat diet
Figure 2 outlines the results of bone densitometry measure-
ments performed using DXA scanning at the conclusion of
the study. BMC was 12.5% lower for yHFD vs. yLFD, and
a decreasing but non-significant trend was observed in the
adult group as well. Whole-body areal BMD (aBMD) was
unaffected in both age groups, as was femoral aBMD. The
most significantly affected mineral measure was spinal
aBMD, which was reduced by 18% in aHFD and 9% in
yHFD compared to their LFD controls, implicating an
increased spinal fracture risk at both age points. Although
vertebral effects were not a part of this study, previous work
by Zernicke et al. [16] found smaller L6 ash content in rats
fed a high-fat–sucrose diet over 2 years.
Bone geometry: cortical bone size effect reversed with age
With respect to the measurements of bone size, femoral
thickness in aHFD was smaller vs. aLFD (p<0.01), likely
due to reduced endocortical bone turnover as measured by
dynamic histomorphometry. yHFD showed an increase in
femoral diameter compared to yLFD (p<0.01),assummarized
in Fig. 3.
Bone histomorphometry measurements: periosteal
and endosteal responses differ with diet
Total cross-sectional area did not change significantly for
either age group but mean cortical width was 5% smaller
in yHFD vs. yLFD (p<0.05). The bone marrow cavity
area was 17% larger in yHFD vs. yLFD (p<0.05), which
is in agreement with the cortical thickness finding and
suggests larger levels of endocortical resorption in yHFD.
The adult marrow area trended larger in HFD as well but
this change was not significant. The endocortical bone
Fig. 1 Body composition, serum leptin concentration, and IGF-I
concentration. a Average weekly weights of LFD and HFD groups.
Horizontal axis is progression of study in weeks; b young and f adult
lean body mass; c young and g adult fat body mass for LFD and HFD
groups at conclusion of study; d young and h adult serum leptin
concentration (mean±SE) at conclusion of study; e young and i adult
serum IGF-I concentrations at the conclusion of study. Both lean body
mass and fat body mass increased, but signficant increase in IGF-I
concentration are only observed for the yHFD group. yLFD n=15,
yHFD n=15, aLFD n=13, aHFD n=14 (
**p<0.01,
***p<0.001)
R
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however, periosteal BFR was higher in both age groups (p
<0.05). Aging may have differential effects on endocort-
ical and periosteal response to HFD, and while the former
decreases the latter may increase. These results are in
agreement with prior aging studies even where obesity is
not a factor; an effect that has been shown to occur
independently of diet where increasing periosteal apposi-
tion is coupled with increasing endocortical remodeling
with age [35].
Fig. 3 Cortical bone size. a Young and d adult cortical thickness is
reduced in adults only; b young and e adult femoral diameters are
increased in yHFD vs. yLFD; c young and f adult femoral lengths are
unchanged. g Histomorphometry results: Ma.Ar. marrow area (mm
2),
T.Ar. total cros-sectional area (mm
2), Mean Ct.Wi. mean cortical width
(μm), Ps.BFR and Ec.BFR periosteal and endocortical bone formation
rate (μm
3/μm
2/γ). The general trend in the bone size data points to
decreasing bone size in adults and increasing bone size in young obese
mice compared to LFD, as well as a shift from periosteal activity to
endosteal activity with age. yLFD n=15, yHFD n=15, aLFD n=13,
aHFD n=14 (
*p<0.05,
**p<0.01,
***p<0.001)
Fig. 2 Bone mineral. a Young and e adult whole-body bone mineral
density (aBMD) is unchanged in HFD; b young and f adult whole-
body areal bone mineral content (BMC) is lower for the yHFD vs.
yLFD, which is likely due to reduced spinal aBMD. c Young and g
adult areal bone mineral density of the femora are unchanged; d young
and h adult areal bone mineral density of the spine are reduced for
HFD despite increasing weight, leptin, and IGF-I. yLFD n=15, yHFD
n=15, aLFD n=13, aHFD n=14 (
***p<0.001)
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The accumulation of AGEs were fluorimetrically quantified
in the decalcified cortex of the HFD and LFD groups.
AGEs are 31% higher in aHFD (42.8±7.6 ng quinine/mg
collagen) vs. aLFD (56.1±9.2 ng/mg, p<0.001) and 6%
higher in yHFD vs. yLFD (41.3±5.5 ng/mg vs. 39.1±
8.7 ng/mg, respectively, p>0.05).
Mechanical testing: mechanical properties compromised
with diabetic obesity
Overall, mechanical properties of cortical bone are
compromised by diabetic obesity in both young and
adult groups, as summarized in Fig. 4. Compared to the
control groups, the yield strength of the bone was
unchanged in aHFD (9% less, not significant), but was
17% less in yHFD (p<0.01); corresponding maximum
strengths were 15% less in aHFD (p<0.05) and 26% less
in yHFD (p<0.01). The bending modulus was 18% less
in aHFD and 32% less in yHFD (p<0.01); fracture
toughness, Kc, values were 21% less in aHFD (p<0.05),
but unchanged in yHFD (8% higher, not significant).
Finally, the maximum loads sustained by the bone were
22% less in aHFD (p<0.01) and 12.5% less in yHFD (p<
0.05). These results indicate a profound reduction in
mechanical quality and performance of the bone with
diabetic obesity.
Structural characterization: poor mineral organization
and lamellar alignment of cortical bone in diabetic
obese mice
SEM was performed on cross-sections of femora near the
fracture surface to evaluate lamellar-level structural
changes. Changes in structure were most apparent at the
posterior site (Fig. 5). In both the young and adult groups,
the HFD bone showed marked areas of lamellar disorgani-
zation, whereas a similar area in the LFD mice appeared
well-ordered.
Fig. 4 Cortical bone quality: whole-bone and tissue-level mechanical
property measurements. a Young and f adult bending modulus; b
young and g adult maximum load; c young and h adult yield stress; d
young and i adult max stress; e young and j adult fracture toughness.
Measured size-independent mechanical properties were significantly
decreased for HFD group vs. LFD groups (modulus, yield and
maximum stress, and fracture toughness); these parameters are an
indication of bone tissue quality. Size-dependent measures which
address whole-bone behavior (specifically, load) also declined for
HFD at both ages, likely due in part to modest bone size changes, as
bone size was not able to compensate for poor mechanical quality.
yLFD n=15, yHFD n=15, aLFD n=13, aHFD n=14 (
*p<0.05;
**p<0.01)
b
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composition or bone mineral measures, most predictive
of mechanical properties
In order to evaluate relationships between bone size,
mechanical properties, and body composition, correlation
analyses were performed between scores for each measure;
correlation coefficients and corresponding p values are
summarized in Table 1 (Q–Q analysis revealed that the data
were normally distributed). In the aLFD, yLFD, aHFD, and
yHFD groups, bone size measures have the highest
negative correlation coefficients with size-independent
mechanical measures, although significance was more
difficult to achieve in the HFD groups. The next highest
predictor of mechanical properties appears to be LBM,
which is not surprising as bone size is highly positively
correlated with LBM. FBM had a weak but negative
correlation with bone size measures, and therefore appears
to have little effect on mechanical properties. BMC affected
mechanical properties more than aBMD, but aBMD is
confounded with bone size. A size-independent measure of
BMD such as volumetric BMD (vBMD) may show a
stronger correlation between mineral distribution and
mechanical properties. Interestingly, size-independent
measures of bone quality (strength, fracture toughness) are
most affected by the size of the bone, which implies a
reduced quality with increasing quantity even in the non-
obese groups.
Discussion
In this study, we have evaluated the effects of diet-induced
obesity on cortical bone and found a large reduction in the
mechanical properties of the cortical bone with diabetic
obesity in both young and adult mice. Although larger bone
size is expected, especially with higher lean body mass [26,
36–39], the mechanical performance of the bone is
nevertheless degraded by the effects of obesity with higher
leptin and IGF-I levels and significantly higher fat body
mass. As higher IGF-I levels are associated with larger
bone size, especially at the periosteum, these data are in
agreement with our observed trends in bone size in the
young group. The slight reduction in IGF-I for adults is also
in agreement with the slight reduction in bone size that was
observed in aHFD. Such reduced mechanical properties are
also consistent with the high blood glucose levels, which
may be a partial contributor to the fracture incidence
observations in diabetic people [4, 13]. Finally, the greater
AGEs with obesity may offer insight into the observed
reduced mechanical properties. Assuming that the levels of
AGEs are normal in the LFD groups, then the elevated
levels in the HFD groups could help explain reduced
fracture toughness [23–25], especially in the adult group, as
the resultant increase in collagen cross-linking can suppress
plasticity in bone by such mechanisms as fibrillar sliding.
We specifically investigated changes in both tissue
quantity, as measured by bone size and mineral content,
Fig. 5 S E Mi m a g e so ft h e
fracture region showing cortical
bone tissue structure changes at
the posterior region. a yLFD
group; b yHFD; c aLFD; d
aHFD. The scale bar indicates
20 μm. The posterior cortex in
HFD bone in (b)a n d( d)s h o w s
reduced alignment of osteocyte
lacunae and reduction in lamellar
alignment at the tissue level.
These images are representative
of three samples each of aHFD,
yHFD, aLFD, and yLFD.
Medial, lateral, and anterior
portions of the bone sections
appeared similar for HFD and
LFD in both age groups
2290 Osteoporos Int (2011) 22:2283–2293and bone tissue quality, which was quantified with histomor-
phometric analyses and qualified by imaging of structural
organization. Geometric effects were small (young mice had
increased diameter, adult mice had reduced cortical thickness,
and other measures were unchanged). The finding of reduced
bone quality is supported by SEM studies which reveal reduced
tissue organization at the micro- and nano-scale and reduced
alignment of lamellae, especially in the posterior quadrant. Both
relatively unchanged bone size and decreasing quality of tissue
suggest that the bone would be less able to perform its load-
bearing function. The reduced ability of bone to bear loads is
supported by large reductions in both the size-dependent and
size-independent mechanical measures. Overall, we see a
reduction of bone tissue quality with minor changes in tissue
quantity (bone size measures) in both adult and young mice.
Correlation analysis supports this finding as size-independent
measures of bone quality (strength, fracture toughness) are most
affected by the size of the bone, which implies a reduced quality
with greater quantity even in the non-obese groups. There are,
however, differences between the two age groups in their
response to obesity, which this work addressed by considering
the effects of diabetic obesity at two stages of an age spectrum.
Additionally, there are changes in bone response to
diabetic obesity with age. Obese adults had smaller femoral
thickness than control adults, while the obese young had
larger femoral diameter compared to young controls. This
shift is supported by greater serum IGF-I concentrations in
young mice. Although not significant, it is possible that age
Table 1 Correlation coefficients between standardized properties in bone from (a)–(d) young and (e)–(h) adult groups
Predictors a. Young LFD (n=15) b. Young HFD (n=15)
Size-independent measures Size-dependent measures Size-independent measures Size-dependent measures
(σy, σu, E) Kc Pu (σy, σu, E) Kc Pu
aBMD −0.3357 0.2225 0.3055 0.0317 0.5767* 0.5089
BMC −0.2654 0.3362 0.4731 0.1793 0.4383 0.2907
(D, t, M.A.) −0.7497** 0.4931 0.1384 −0.4951 0.0037 0.214
LBM −0.4108 0.319 0.3969 −0.2584 0.0167 0.1194
FBM 0.1384 −0.2299 −0.1014 0.1582 −0.4439 −0.2404
c. Bone size in LFD—(D, t, M.A.) d. Bone size in HFD—(D, t, M.A.)
LBM 0.8133*** 0.4982
FBM −0.1433 −0.4298
Predictors e. Adult LFD (n=13
a) f. Adult HFD (n=14)
Size-independent measures Size-dependent measures Size-independent measures Size-dependent measures
(σy, σu, E) Kc Pu (σy, σu, E) Kc Pu
aBMD 0.0808 0.2741 0.0574 −0.4976 0.2376 −0.2333
BMC −0.1709 0.1131 0.3577 −0.4312 −0.0746 −0.0991
(D, t, M.A.) −0.5559* 0.3858 0.7536* −0.5046 −0.3889 0.4426
LBM 0.1485 0.3775 0.5138 −0.2061 −0.1537 0.6519*
FBM −0.1075 0.0715 −0.4535 −0.1394 −0.3774 −0.0796
g. Bone size in LFD—(D, t, M.A.) h. Bone size in HFD—(D, t, M.A.)
LBM 0.4587 0.6377*
FBM −0.1284 −0.0023
Coefficients from correlation analysis applied between standardized mechanical properties and standardized bone and physiological properties of
(a), (c) young LFD group; (b), (d) young HFD group; (e), (g) adult LFD group; (f), (h) adult HFD group. In cases where measurements were
related and highly positively correlated, a composite score was used in the analysis. Bone size is the largest predictor of mechanical properties,
more so than bone mineral measures or body composition. Interestingly, size-independent measures of bone quality are most affected by the size
of the bone, which implies a reduced quality with increasing quantity. Correlation coefficients between body mass measures and bone size
measures show that LBM is positively correlated with bone size in both groups (c), (d), (g), (h) and that FBM is very weakly negatively correlated
with bone size. Correlation coefficients are conducted separately for young and adult groups
vBMD volumetric bone mineral density, M.A. second moment of area, A Ct. cross-sectional area, Ro outer Ct. Rd, LBM lean body mass, FBM fat
body mass, σy yield strength, σu maximum strength, E bending modulus, Kc fracture toughness, Py yield load, Pu maximum load, (D, t, M.A.)
composite bone size score, (σy, σu,E )composite strength and modulus score
*p<0.05,
**p<0.01,
***p<0.001
aOne mouse died in week 4 of the study from fighting
Osteoporos Int (2011) 22:2283–2293 2291decreases the ability of bones to increase in size in response
to increasing obesity. This inability of bone size to respond
to increased weight coupled with the observed degraded
mechanical properties suggests that adults are just as at risk
for bone fracture, if not more so, than the young group
when diabetes is present. These findings in a mouse model
agree with human fracture rates, which increase in diabetic
obesity for both young and adults [4, 13].
Thisstudyislimitedinthatmarkedlygreaterbloodglucose
levels were observed, and this potential diabetic state likely
interferes with the body’s tendency to increase bone size in
response to increasing leptin, IGF-I, and body weight as
would otherwise be expected. Our results support those of
Garris et al. who found reduced hind limb bone maturation in
db/db (diabetic) and ob/ob (obese) mice relative to controls
[40]. Our prior study [19], which used a different low-fat diet
but the same high-fat diet, found a smaller effect on blood
glucose levels over a longer period of time (19 weeks) and
also a much larger effect on bone size (markedly greater
cortical bone parameters). It is therefore highly likely that the
differences in the two studies (i.e., reduced effect in bone
size, whereby cortical size parameters seem to be relatively
unchanged by obesity in this work) results from the
additional burden of diabetes. Studying mouse models that
are less susceptible to hyperglycemia may show larger
effects in the bone size such as those observed in non-
diabetic humans. Additional study is warranted to investigate
how the findings in this study are reflected in humans.
Overall, we observed a marked reduction in mechanical
performance of cortical bone in both adults as well as
adolescents with obesity. Modest bone size changes were
observed, although the trend appears to change from greater
bone size in young obese mice to smaller bone size in adult
obese mice as compared to their respective lean controls.
Both the bone size and surface-based bone turnover
investigations are in agreement with the reversing serum
IGF-I concentration, smaller in young and trending larger in
adults. These observations are in agreement with human
fracture incidence data where increasing fracture rates
accompany diabetic obesity. Factors such as hormone
levels and blood glucose levels dramatically influence the
effects of obesity on bone, and may even cancel out the
compensatory mechanisms such as the tendency of bone to
increase its size in response to increasing body size.
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